Evidence map›Paper›PMID 41867859›Full record

ArticlebioRxiv : the preprint server for biology2026

EpiExpr: Predicting gene expression using epigenetic data and chromatin interactions.

Sourya Bhattacharyya, Ferhat Ay

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sourya BhattacharyyaLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0002-5767-8168
Ferhat AyLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0002-0708-6914

Funding

Studying the function of human genetic variation in the light of 3D genome organizationR35GM128938 · NIGMS · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Ferhat Ay · 2018 to 2026
$4.6M
NIGMS NIH HHS R35 GM128938
6 · The paper itself

Abstract

Decoding gene expression from epigenomic landscapes remains a fundamental challenge in genomics. We introduce EpiExpr, a flexible deep learning framework that predicts gene expression from 1D epigenetic tracks (EpiExpr-1D) and integrates 3D chromatin interactions (EpiExpr-3D) to capture distal regulatory effects. Leveraging residual convolutional networks and graph neural networks, including graph attention and graph transformer models, EpiExpr models both local and long-range regulatory influences. Applied to GM12878 and K562 cells, EpiExpr-1D and 3D improve gene expression prediction relative to reference approaches. Analysis using CRISPRi-FlowFISH validated enhancers confirms that EpiExpr-3D accurately prioritizes regulatory elements, compatible with activity-by-contact scores. Remarkably, EpiExpr achieves performance comparable to DNA sequence-based transformer models without requiring sequence embeddings, offering a computationally efficient alternative. This approach provides a scalable, multi-resolution framework (https://github.com/souryacs/3CExpr) for dissecting the contributions of epigenetic modifications and 3D genome organization to gene regulation, enabling broader application across cell types and experimental settings.

Identifiers

PMID41867859
PMCPMC13001461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.